LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 39 filers reported holding LOGICBIO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -62.5% | 11,768 | -46.7% | 0.00% | – |
| Q2 2022 | $8,000 | 0.0% | 22,096 | +75.9% | 0.00% | – |
| Q1 2022 | $8,000 | +14.3% | 12,561 | +316.8% | 0.00% | – |
| Q4 2021 | $7,000 | +40.0% | 3,014 | +163.2% | 0.00% | – |
| Q3 2021 | $5,000 | -68.8% | 1,145 | -68.3% | 0.00% | – |
| Q2 2021 | $16,000 | -30.4% | 3,610 | +14.9% | 0.00% | – |
| Q1 2021 | $23,000 | +53.3% | 3,143 | +62.3% | 0.00% | – |
| Q4 2020 | $15,000 | -86.1% | 1,936 | -83.7% | 0.00% | -100.0% |
| Q3 2020 | $108,000 | +535.3% | 11,913 | +500.8% | 0.00% | 0.0% |
| Q2 2020 | $17,000 | +54.5% | 1,983 | -11.8% | 0.00% | 0.0% |
| Q1 2020 | $11,000 | -45.0% | 2,249 | +47.7% | 0.00% | 0.0% |
| Q2 2019 | $20,000 | +233.3% | 1,523 | +150.1% | 0.00% | – |
| Q1 2019 | $6,000 | – | 609 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 500,000 | $2,470,000 | 0.65% |
| Orbimed Advisors | 6,466,783 | $31,946,000 | 0.54% |
| SAMLYN CAPITAL, LLC | 798,566 | $3,945,000 | 0.10% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 915,355 | $4,522,000 | 0.01% |
| IHT Wealth Management, LLC | 11,660 | $58,000 | 0.01% |
| FIDUCIARY TRUST CO | 37,998 | $188,000 | 0.01% |
| FRANKLIN RESOURCES INC | 700,000 | $3,458,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 13,700 | $68,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,249 | $11,000 | 0.00% |
| MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |